Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, Keith D., Bowlus, Christopher L., Boyer, James, Levy, Cynthia, Mayo, Marlyn·2019·Hepatology
DOI 10.1002/hep.30145

Cited by (924)

Items 701–800 of 924

  1. Advanced PBC
    Juan Pablo Trivella · 2023 · Springer eBooks
  2. Psychological factors and biochemical indicators influencing sleep disturbance of patients with primary biliary cholangitis in China: a cross-sectional survey analysis
    Chenyang Zhao, Bo Zang, Qixuan Liu, Bingqian Liu, Yuan Yao, Hua Li, Yifei Yang, Bin Liu · 2024 · Frontiers in Medicine
  3. Autoimmune liver damage in patients with primary Sjogren's syndrome associated with anticentromeric antibodies
    B. D. Chaltsev, Vladimir Vasiliev, S G Palshina, Anna Vasilyevna Torgashina, E. Sokol, Yu. I. Khvan, Ekaterina B. Rodionova, Tatiana N. Safonova, Т. П. Некрасова · 2021 · Modern Rheumatology Journal
  4. Fenofibrate discontinuation and the association with clinical outcomes in primary biliary cholangitis patients receiving combination therapy
    Shuhao Su, Jiaqi Yang, Jie Luo, Caiyun Yang, Chongxiao Li, Xingchen Liu, Guanya Guo, Y Han · 2026 · International Journal of Clinical Pharmacy
  5. Progress in diagnosis and treatment of non-cirrhotic portal hypertension associated with primary biliary cholangitis
    Lin-Xiang Huang, Bo Feng · 2026 · World Chinese Journal of Digestology
  6. Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical Trial (Preprint)
    2020
  7. Coriobacteriia Can Affect The Developing of Hepatocellular Carcinoma Through The Pyrimidine, Caffeine, Urea Cycle and Glutamate Metabolic Pathways
    Jingyi Dai, Qiujing Li, Jie Chen · 2024 · Research Square
  8. Changing epidemiology and treatment responses in autoimmune liver diseases: a 14-year retrospective analysis from a tertiary care center
    Buğra Kaan Bahçeci, Ömer Küçükdemirci, Müge Ustaoğlu, Hasan Eruzun, Ahmet Bektaş · 2024 · Egyptian Liver Journal
  9. Serological and clinical features in patients with anti‐centromere antibody positivity
    Taro Horino · 2026 · European Journal of Internal Medicine
  10. Identifying the clinical signature of anti-centromere antibody-positive Sjögren’s syndrome: a machine learning-based analysis of a multicenter cohort
    Wenlong Zhu, Ting Fang, Xinchao Zhu, Zhe Yang, Jiayao Wang, X Wang · 2026 · Frontiers in Immunology
  11. Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
    İlkay Ergenç · 2024 · Hepatology forum/Hepatology forum (Online)
  12. Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis
    Sha Chen, Buer Li, Shuxiang Li, Tingting Lv, Qin Xiao, Hong Ma, Yu Wang, Xinyan Zhao, Xiaojuan Ou, Yuanyuan Kong et al. · 2026 · BMC Gastroenterology
  13. Medical management of portal hypertension and its complications
    Mohammad Qasim Khan, Patrick S. Kamath · 2023
  14. Prevalence of Celiac Disease in Autoimmune Liver Diseases
    Sena FİDAN, Selver Yaylamaz Kustu, Tuğçe Eşkazan · 2026 · Hepatitis Monthly
  15. Progress in Liver Cancer Associated to Autoimmune Liver Disease
    Danlin Wang, Liang Song, Lei Guan, Yi Lu, Ying Han · 2025 · Journal of Contemporary Medical Practice
  16. Safety profile of elafibranor versus placebo in primary biliary cholangitis
    Naveed Ahmed Khan, Hunain Shahbaz, Muhammad Talha, Muhammad Abdullah Khan, Muhammad Aliyan Tahir, Umar Anwar, Muhammad Saleem Khan, Pukar Adhikari · 2026 · Medicine
  17. The diagnostic performance of non-invasive fibrosis markers for predicting fibrosis in primary biliary cholangitis patients
    Nermin Mutlu Bilgiç, Gupse Adalı · 2024 · Turkish Journal of Clinics and Laboratory
  18. Fatigue, weakness, and sleep disturbances in liver disease: Diagnosis and patient management
    K. L. Raikhelson, Mikhail Gur'evich Poluektov, D. S. Petelin, Anna F. Sheptulina · 2026 · Meditsinskiy sovet = Medical Council
  19. Hepatopatías autoinmunes. Hallazgos clínicos y de laboratorio en pacientes de un hospital de referencia nacional
    Julián David Martínez Marín, Sandra Consuelo Henao Riveros, Martín Garzón-Olarte · 2021 · Hepatología
  20. Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis
    Yinling Li, Huanhuan Xie, Zhenjie Zhuang, Xin Fang, Wenjun Yang, Yan Luo, Jiangyi Hu, Wei Wang, Haitao Wang, Xiaobing Dou et al. · 2026 · European Journal of Pharmacology
  21. Characterization of a Northern German Primary Biliary Cholangitis Cohort
    Heike Bantel, Yunus Fatih Kader, Katharina John, Martin Franck, Heiner H. Wedemeyer · 2026 · Zeitschrift für Gastroenterologie
  22. Validation of a Multiparametric, Automated, Macroarray‐Based Assay for the Detection of Autoantibodies in Autoimmune Liver Disease
    Luigi Raganelli, Tommaso Bandini, Matilde Ilacqua, Helena Cerutti, Alessandra Cartocci, Giulia Tesi, Andrea Ianniello, Thomas Massari, Mirko Berretti, Roberto Centini et al. · 2026 · Journal of Clinical Laboratory Analysis
  23. Efficacy of ursodeoxycholic acid and corticosteroids for patients with hepatic form of primary biliary cholangitis
    Yuki Sasaki, Masayuki Ueno, Kenji Notohara, Masahiko Sue, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Hiroshi Yamamoto, Motowo Mizuno · 2020 · Kanzo
  24. The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases
    Soon Kyu Lee, Soon Kyu Lee, Sung‐Soo Park et al. · 2024 · Diagnostics
  25. A low baseline serum myostatin concentration is associated with poor clinical outcome in patients with primary biliary cholangitis
    Manabu Hayashi, Kazumichi Abe, Tatsuro Sugaya, Yosuke Takahata, Masashi Fujita, Atsushi Takahashi, Hiromasa Ohira · 2024 · Journal of Gastroenterology and Hepatology
  26. PBC-AIH Overlap
    Juan Pablo Trivella · 2023 · Springer eBooks
  27. Terapias usuales y emergentes en colangitis biliar primaria
    Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez · 2022 · Hepatología
  28. Evaluation of the Use of Naltrexone for Cholestatic Pruritus
    Andrew J. Sweigart, Astrela Moore, Rebecca Kendsersky, Amit A. Shah, Jessica Zook · 2023 · The Journal of Pediatric Pharmacology and Therapeutics
  29. Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
    Kun Yang, Bingqing Yang, Jiamin Chen, Lili Gao, Xiaoyi Han, Junke Hu, Liang Zhang, Xiangmei Chen, Qi Wang, Xingang Zhou et al. · 2026 · BMC Gastroenterology
  30. Understanding the Burden of Itch in Primary Biliary Cholangitis: Reliable Patient Reported Outcomes Tools are the Key to Effective Pruritus Assessment and Management
    Amanda Barrell · 2025 · EMJ Hepatology
  31. Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation
    Alexandra D. Frolkis, Jeremy Shanika Nayagam, Alessandro Parente, Matthew John Seager, Matthew D Sadler, Aldo J. Montaño‐Loza, Deepak Joshi · 2026 · JHEP Reports
  32. Meaningful Improvement Thresholds for Pruritus and Sleep Disturbance in PBC Using the Worst Itch and Sleep Interference Numerical Rating Scales
    Brooke M. Currie, Katelyn N. Cutts, Ren Yu, Yipin Han, Gideon Morris Hirschfield, Cynthia Levy, Megan McLaughlin, Marlyn J. Mayo, David E. Jones, Heather L. Gelhorn · 2026 · Advances in Therapy
  33. Severe Hypercalcemia and Acute Kidney Injury in a Patient with Probable IgG4-Related Disease and Cholestatic Liver Injury: A Case Report
    Chi-Hsien Chang, Shang‐Feng Tsai · 2026 · Journal of Clinical Medicine
  34. Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases
    Takahiro Nagata, Yasuaki Takeyama, Satoshi Shakado, Fumihito Hirai, Satoshi Nimura · 2023 · Cureus
  35. Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis
    Jing Feng, Zhiyun Liu, Huanna Sun · 2026 · PLoS ONE
  36. An experimental study on the effect of symptom expectations on mental fatigue and motivation in people with primary biliary cholangitis
    Laura Buck, Jule Herzberg, Bert Lenaert, Bernd Löwe, Johannes Hartl, Christoph Schramm, Anne Christin Toussaint · 2025 · Scientific Reports
  37. Postpartum may be a risk factor for biochemical flares in patients with primary biliary cholangitis: A single-center experience
    Yi Wei, Yansong Huang, Xu Wang, Lina Zhang, Kunyu Zheng, Yunjiao Yang, Yanlei Yang, Chengmei He, Qiao Lin, Yongzhe Li et al. · 2025 · Clinical Rheumatology
  38. MELD and the Risk of Mortality Between Black and White Patients with Advanced Fibrosis
    Michael L. Attanasi, Mathew J. Gregoski, Don C. Rockey · 2026 · Digestive Diseases and Sciences
  39. Metabolomics-based Investigation of Primary Biliary Cholangitis: A Cholestatic Liver Disease
    Juliana Magalhães de Oliveira, Thaís de Assis Lopes, Alex Castro, Étore De Favari Signini, Aparecida Maria Catai, Antonio Gilberto Ferreira, Eduardo Luiz Rachid Cançado, Regina V. Oliveira · 2024 · Research Square
  40. Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective
    Simone Irene Strasser, Alexander J. V. Thompson, Rohit Gupta, John Samuel Lubel, Janine French, Beverly Sacks, Martin Weltman · 2026 · Journal of Gastroenterology and Hepatology
  41. The Diagnostic Pathway for Patients with Cholestatic Liver Disease
    Adrielly Martins, Rodrigo Vieira Motta, Guilherme Grossi Lopes Cançado · 2026 · Clinics in Liver Disease
  42. Efficacy, symptoms, and safety of second-line PBC therapies: a network meta-analysis
    Wenbin Zhao, Zhichao Wu, Qingyan Kou, Shengxian Qiao, Zhenyuan Liu, Xu Zhang · 2026 · Frontiers in Pharmacology
  43. Elastography in Autoimmune Liver Diseases
    Laura Cristoferi, Marco Carbone, Pietro Invernizzi · 2021 · Springer eBooks
  44. ATF3 Mediates the Immunoregulatory Role of the Tim‐3 Pathway in Primary Biliary Cholangitis
    Jiamin Xu, Haitao Ma, Wenxia Yang, Rongfang Tu, Hua Lin, Yang Feng, Simiao Li, Weimin Bao, Yingmei Tang · 2026 · Journal of Gastroenterology and Hepatology
  45. A Preliminary Study on Clinical Characteristics of Patients With Autoimmune Liver Following Coronavirus Disease 2019
    Chenchen Yang, Yu Hu, Juanjuan Fu · 2025 · Journal of Tropical Medicine
  46. Challenges for diagnosis and treatment of primary biliary cholangitis
    Atsushi Tanaka · 2023 · Elsevier eBooks
  47. Primary Biliary Cholangitis: Predictors of Poor Response to Ursodeoxycholic Acid after 1 Year of Treatment in Moroccan Patients
    Hakima Abid, Inssaf Akoch, María Lahlali, Nada Lahmidani, Mounia El Yousfi, D. A. Benajah, Mohamed El Abkari, Adil Ibrahimi · 2021 · Journal of Medical and Surgical Research
  48. Biomarcadores em Hepatologia
    Elze Maria Gomes Oliveira, Maria Lúcia Gomes Ferraz · 2019 · Revista Paulista de Reumatologia
  49. Primärärztliche Labordiagnostik autoimmuner Lebererkrankungen – Short review
    Dirk Moßhammer, Matthias Reichert · 2024 · DMW - Deutsche Medizinische Wochenschrift
  50. Serological markers of rheumatoid arthritis in patients with primary biliary cholangitis and the vice versa: A Tunisian study
    Mariam Ghozzi, Amani Mankaï, Inssaf Zneidi, Wiem Manoubi, Sarra Melayah, Fatma Mechi, Abdelhalim Trabelsi, Ibtissem Ghédira · 2023 · Immunobiology
  51. Mineral disorders in patients with chronic liver disease. Part 2: management
    Olga Spasskaya, Горбачева Анна Максимовна, Бибик Екатерина Евгеньевна, I. N. Tikhonov, Еремкина Анна Константиновна, А. V. Khairieva, E. E. Litvinova, N G Mokrysheva · 2026 · Obesity and metabolism
  52. 10.1016/s1155-1976(19)80145-6
    2000 · Time to knit
  53. Thinking Outside of Urso
    Aaron Hakim, Vilas R. Patwardhan, Alan Bonder · 2020 · Clinical Liver Disease
  54. Extrapulmonale Sarkoidose mit Multiorganbeteiligung: ein komplexer Fall mit renaler, neurologischer und gastrointestinaler Manifestation
    Julian Müller-Kühnle, Chantal Laboureur, Laura Wiedemann et al. · 2026 · Die Innere Medizin
  55. Overlap Syndrome and Myasthenia Gravis: An Uncommon Association With Unusual Features
    Gautam Ray · 2019 · ACG Case Reports Journal
  56. Decline of Persistent Jaundice in a Patient With Autoimmune Hepatitis and Vanishing Bile Duct Syndrome Treated With Elobixibat for Constipation
    Tân Trần Thị, Norihiro Imai, Yosuke Inukai, Takashi Honda, Hiroki Kawashima · 2025 · Cureus
  57. General Hepatology Concerns for the Patient with Cholestatic Liver Disease.
    Maya Deeb, Michelle Ma · 2026 · Clinical Liver Disease
  58. Up to 1 in 4 Veterans With Primary Biliary Cholangitis May Have Cirrhosis by the Time of Its Diagnosis
    Robert J. Wong, Zeyuan Yang, Ramsey C Cheung · 2026 · Gastro Hep Advances
  59. Evalucation of differences in clinical and laboratory parameters in the combination of primary biliary cholangitis and associated diseases
    B. A. Abilbekova, A. Zh. Satmetova · 2023 · Экспериментальная и клиническая гастроэнтерология
  60. EP547 (MRGPRX4 inverse agonist) for cholestatic pruritus due to primary biliary cholangitis or primary sclerosing cholangitis: Results from the phase 2 randomized, placebo-controlled PACIFIC study
    Cynthia Levy, David Jones, Gideon M. Hirschfield · 2026 · Annals of Hepatology
  61. Case Report: Acute presentation of autoimmune hepatitis in a male patient
    Aya Hammami, Khouloud Ben Abdessalem, Sarra Mestiri, Nour Elleuch, Wafa Dahmani, W. Ben Ameur, M. Ksiaa, Aida Ben Slama, Salem Ajmi, Ahlem Braham et al. · 2021 · F1000Research
  62. BÁO CÁO CA BỆNH XƠ GAN MẬT TIÊN PHÁT (PRIMARY BILIARY CHOLANGITIS)
    Ngọc Anh Đới, Ngọc Phúc Nguyễn, Thanh Dũng Lê, Hoai Linh Vu, Xuân Hải Đào, Sỹ Lánh Nguyễn, Duy Thành Trần · 2020 · Tạp chí Truyền nhiễm Việt Nam
  63. A woman with anti-mitochondrial antibody-negative primary biliary cholangitis for a long-term intermittent elevated hepatic enzymes: a case report
    Shukai Zhan, Jun-Feng Zhu, Xi Deng, Eddie C. Chueng, Youpeng Chen · 2021 · Digestive Medicine Research
  64. Respiratory Mechanics, Respiratory Muscle Strength, Control of Ventilation and Gas Exchange in Patients with Autoimmune Liver Disease
    Ahmet Baydur, Jacob Korula · 2024 · Open Journal of Respiratory Diseases
  65. Fenofibrate add-on therapy improves transplant-free survival in patients with primary biliary cholangitis refractory to ursodeoxycholic acid
    Buer Li, Shuxiang Li, Sha Chen, Min� Li, Tingting Lv, Qianyi Wang, Xiaomin Wang, Yu Wang, Hong Ma, Xiaojuan Ou et al. · 2022 · Research Square
  66. Label-Free Urinary Proteomics Uncovers Immune-Related Non-Invasive Biomarkers for Primary Biliary Cholangitis
    Xiong Pei, Ting Lei, Wei Jiang, Qingmin Zeng, Hong Tang, Taoyou Zhou, Dongbo Wu · 2026 · International Journal of Molecular Sciences
  67. Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Richard J. Bower, Catherine T Frenette · 2020 · The American Journal of Gastroenterology
  68. Metabolomic Machine Learning Predictor for Adequate and Deep Response to UDCA in Non‐Cirrhotic PBC
    F Yang, Jin Lin, Yu Zhang, Xiaoyan Ao, M J Shen, Tingting Jia, Zhou Leyu, Xiaoli Fan, Li Yang · 2026 · Liver International
  69. Case Report: Multiple Autoimmune Syndrome—A Multidisciplinary Clinical Approach to a Spectrum of Organ Involvement
    Jia Tang, Xiucai Fang, Jun Li Feng · 2025 · International Journal of Rheumatic Diseases
  70. Comment on “Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan”
    MeiLing Jin · 2025 · Journal of the Formosan Medical Association
  71. Primary Biliary Cholangitis
    Andrew R. Scheinberg, Cynthia Levy · 2022 · Current treatment options in gastroenterology
  72. WITHDRAWN: Bibliometric Analysis of Research Trends and Future Development Directions in Bile Acids and Primary Biliary Cholangitis
    Qi Gao, jing cheng, Pan Li, Zhe Ma · 2025 · Research Square
  73. Non-viral or Drug-Induced Causes of Acute Liver Failure
    Nyan L. Latt, Sanjaya Kumar Satapathy · 2020 · Springer eBooks
  74. Autoimmune Biliary Diseases: From Fragmented Pathways to Precision Diagnosis
    Anthony Bedran, Karim Hoyek, Doha A. Houcheimy, Joanna Kreidi, Angelo Chami, Serena Nabhan, Karam Karam, Khalil Bedran · 2026 · Sage Open Pathology
  75. Clinical significance of anti-rheumatoid arthritis 33 antibody in patients with systemic lupus erythematosus
    Wenyi Lu, Xiaoping Hong, Jingyi Xie · 2023 · Journal of Investigative Medicine
  76. Clinicopathological and Imaging Features of Primary Biliary Cholangitis
    Mengdan Xie, Custon Tafadzwa T. Nyabanga, Mantej Sehmbhi, Nour Al Khalili, Christy Chon, Amita Kamath, Amreen M. Dinani, Ilan S. Weisberg · 2022 · medRxiv
  77. Primary biliary cholangitis review – new management strategies emerge
    Elizabeth Gatley, Neliswa A. Gogela, Mark Wayne Sonderup · 2025 · South African journal of gastroenterology and hepatology.
  78. Combination With Glucocoriticoids and/or Immunosuppressants Brings Few Benefits in Patients With Primary Biliary Cholangitis
    Zilong Wang, Rui Jin, Mei Hao, Yandi Xie, Hao Wang, Bo Feng · 2021 · Research Square
  79. Alterations in Gamma-Delta T Cells in Patients With Primary Biliary Cholangitis
    Sha Chen, Tingting Lv, Guangyong Sun et al. · 2021 · Research Square
  80. Nutrition in Cholestatic Liver Disease
    Daniela Goyes, C. Danford, Hirsh D. Trivedi, A. Bonder · 2020 · Current Hepatology Reports
  81. Naltrexone
    Meghan N. Breckling, Morgan Streett · 2026 · Elsevier eBooks
  82. The association of primary biliary cholangitis with metabolic syndrome and metabolic dysfunction-associated steatotic liver disease
    Maya Mahmoud, Mohamed Awali, Wing-Kin Syn, Kamran Qureshi · 2026 · Exploration of Digestive Diseases
  83. WITHDRAWN: Bibliometric Analysis of Research Trends and Future Development Directions in Bile Acids and Primary Biliary Cholangitis
    Qi Gao, jing cheng, Pan Li, Zhe Ma · 2025 · Research Square
  84. Primary Biliary Cholangitis
    Patrick S.C. Leung, Tihong Shao, Li Wang, Koichi Tsuneyama, Pietro Invernizzi, Suraj Timilsina, M. Eric Gershwin · 2024 · Springer eBooks
  85. PSC-AIH Overlap
    George N. Dalekos, Nikolaos Gatselis · 2020 · Springer eBooks
  86. The liver and gallbladder in the geriatric population
    Gary Trey · 2022 · Pathy's Principles and Practice of Geriatric Medicine
  87. Cholestatic Diseases, Chronic
    Simon D. Hohenester, Gerald Denk · 2019 · Encyclopedia of Gastroenterology
  88. Vanished Without a Trace: A Middle‐Aged Man With Vanishing Bile Duct Syndrome—A Case Report
    Edwin Mendoza, Alan Jurado, Virali Gulla · 2026 · Case Reports in Gastrointestinal Medicine
  89. Microorganisms in the Pathogenesis and Management of Primary Biliary Cholangitis (with Focus on SARS-CoV-2 & Gut Microbiota)
    Matei-Alexandru Cozma, Camelia Cristina Diaconu · 2022 · Springer eBooks
  90. Challenges facing the PBC community: insights from the PBC International Summit
    Robert Mitchell-Thain, Alexander Artyomenko, Stephen I.G. Barclay, Alan Bonder, Stefan Carlsson, Mo Christie, Emma Louise Culver, Daphne D’Amato, Klara Dickinson, Robert Gareth Gish et al. · 2025 · Frontline Gastroenterology
  91. Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond
    Bushra Qasim, Hina Kumari, Syeda Naveera Kashif, Syed Muhammad Iraj Abbas, Omme Hani, Omme Salma, Ahsan Sauleh, FNU Adnan, Mashooque Ali, Abdul Raheem et al. · 2025 · Egyptian Liver Journal
  92. Cholestasis
    Marianna G. Mavilia, George Y. Wu · 2021 · Clinical gastroenterology
  93. FCRL3 as a potential link between Benzo[a]pyrene exposure and primary biliary cholangitis: insights from comparative toxicogenomics and multi-omics analysis
    Zongze Han, Ying Ran, Ruiyun Liu, Shijing Dong, Jiwen Li, Xue Zhang, N Chen, Can Wang, Bangmao Wang, Simin Zhou et al. · 2026 · BMC Gastroenterology
  94. Liver transplant and autoimmune liver diseases: An up-to-date review
    João P C Freire, Caio Ferraz Lopes, Pedro H M Lima, Lucas Dias Feliciano, Fabrício Freire de Melo · 2026 · World Journal of Gastrointestinal Surgery
  95. Recommendations and quality criteria to improve the early diagnosis of primary biliary cholangitis
    Álvaro Díaz‐González, Noelia Fontanillas, Eva Gil-Hernández, Mercedes Guilabert, María‐Carlota Londoño, Mar Noguerol, Fernando Pérez Escanilla, José Joaquín Mira, Manel Santiñà · 2024 · Gastroenterología y Hepatología (English Edition)
  96. Serum asprosin level is significantly lower in patients with liver cirrhosis than in those with non-cirrhotic chronic liver diseases
    Sichao Wang, Yan Wang, Shujun Zhang, Tao Li, Xinli Zhou, Li Chen · 2025 · Frontiers in Endocrinology
  97. Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation
    Fatma Megdiche, Nour Siala, Faten Kallel, Imen Krichen, Hend Hachicha, Imen Frikha, Maha Charfi, Naourez Kallel, Moez Medhaffar, Hatem Masmoudi et al. · 2025 · Future Science OA
  98. Seronegative Primary Biliary Cholangitis in a Middle Age Male- A Rare Entity
    Kamal Deep Singh, Jaspreet Kaur, J Kaur · 2020 · Journal of Evidence Based Medicine and Healthcare
  99. Significance of auto-antibodies in living donor liver transplantation: A scoping review
    Bochao Jiang, Chanda Kendra Ho, Thinesh Lee Krishnamoorthy · 2025 · Annals of Liver Transplantation
  100. Comparação da eficácia terapêutica entre o ácido ursodesoxicólico manipulado e sua apresentação comercial na colangite biliar primária: avaliação dos eventos adversos e custos do tratamento
    Larissa Akeme Nakano · 2020